Video

Karuppiah Kannan on the Past and Future of Myeloma Treatment

Author(s):

Karuppiah Kannan

Karuppiah Kannan, associate director at Takeda Pharmaceuticals, talks about the progress made in treating myeloma and where the field is going in the future.

Karuppiah Kannan, associate director at Takeda Pharmaceuticals, talks about the progress made in treating myeloma and where the field is going in the future.

About a decade ago, Kannan says that a myeloma diagnosis was like a death sentence, with low five- and ten-year survival rates. Now, advances in medicine are allowing people with the disease to live longer, more normal lives, but work still needs to be done to find a cure.

Related Videos
Image of a woman with long red hair.
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Image of a man with short black hair.
Image of a woman with tied back hair, wearing pearl earrings.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Image of man with gray hair.
Related Content
image of breast cancer cells.
October 25th 2024

Jenna Fischer Shares Breast Cancer Details, Los Angeles Dodgers Broadcaster in Remission and More

Alex Biese Ashley Chan
From “The Office” star opening up in a new interview to Charley Steiner revealing his multiple myeloma journey, here is this week’s cancer news.
Top Headlines on CAR-T Cell Therapy
December 4th 2023

Top Headlines on CAR-T Cell Therapy

Alex Biese Brielle Benyon
From FDA concerns to a potential new drug, CAR-T cell therapies were dominating oncology headlines last week.
Image of "Multiple Myeloma" written on a paper with pills around it.
October 9th 2024

Ninlaro Combo Delays Post-Transplant Progression in Relapsed Myeloma

Alex Biese
Ninlaro, Thalomid and dexamethasone followed by Ninlarlo maintenance may improve durability of response in myeloma after stem cell transplantation relapse.
Health Care Worker Discusses Cancer Diagnosis and Vaccine Experience While on the Frontlines of the COVID-19 Pandemic
January 13th 2022

Health Care Worker Discusses Cancer Diagnosis and Vaccine Experience While on the Frontlines of the COVID-19 Pandemic

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a physician assistant recalls his experience as a frontline health care worker during the COVID-19 pandemic and what it was like to get diagnosed with multiple myeloma during such a chaotic time.
Illustration of a man with rectangular glasses.
October 3rd 2024

Understanding Multiple Myeloma Symptoms

Ronald Chin
Reflecting on the pain I experienced before my diagnosis of multiple myeloma, I realized how important it was to pay attention to the related symptoms.
Illustration of cells.
September 23rd 2024

Outpatient CAR-T Cell Therapy May Be Safe in Hematologic Malignancies

Spencer Feldman
CAR-T cell therapies administered in an outpatient setting may be safe and feasible without intensive remote monitoring in hematologic malignancies.